"10.1371_journal.pone.0107582","plos one","2014-10-08T00:00:00Z","Ott Saluveer; Pia Larsson; Wilhelm Ridderstråle; Thórdís J Hrafnkelsdóttir; Sverker Jern; Niklas Bergh","The Wallenberg Laboratory for Cardiovascular Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Cardiology, Landspitali University Hospital and the University of Iceland, Reykjavik, Iceland","Conceived and designed the experiments: SJ NB TH OS PL. Performed the experiments: OS NB WR. Analyzed the data: OS NB SJ TH. Contributed reagents/materials/analysis tools: OS PL WR SJ NB. Wrote the paper: OS NB SJ PL.","O. S., N. B., P. L. and S. J. are together with Gothenburg University Holding Company shareholders in a company to handle the intellectual property of a PCT patent application: PCT/GB2012/000229 Method for improving impaired endogenous fibrinolysis using histone deacetylase inhibitors (inventors: P. L., N. B., S. J.), filing date March 9, 2012. None of the authors are employed by the company. The company has had no influence on study design or data interpretation and the company has no products in development. The authors confirm that this competing interest does not alter their adherence to PLOS ONE policies on sharing data and materials. There are no restrictions on sharing of data and/or materials.","2014","10","Ott Saluveer","OS",6,TRUE,5,3,4,4,TRUE,TRUE,FALSE,0,NA,FALSE
